Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas

被引:73
作者
ProbstHensch, NM
Haile, RW
Li, DS
Sakamoto, GT
Louie, AD
Lin, BK
Frankl, HD
Lee, ER
Lin, HJ
机构
[1] UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,DEPT PREVENT MED,LOS ANGELES,CA 90033
[2] KAISER PERMANENTE,DEPT GASTROENTEROL,LOS ANGELES,CA 90027
[3] UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV GEN MED,TORRANCE,CA 90502
关键词
D O I
10.1093/carcin/17.10.2125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Smoking and a high intake of red meat are risk factors for colorectal tumors, These effects could be due to aromatic amine carcinogens. Individual susceptibility to aromatic amines has been related to acetylation phenotype, which plays a role in the bioactivation of arylamines. Polymorphisms in both N-acetyltransferase genes, NAT1 and NAT2, have been associated with an increased risk of colorectal tumors, We studied the NAT1*10 fast acetylator allele (1088 T-->A mutation) and distal adenomas in a sigmoidoscopy-based case-control study (441 cases, 484 controls), We found neither an increased adenoma prevalence in subjects homozygous or heterozygous for the NAT1*10 fast acetylator allele (odds ratio 1.04; 95% confidence interval 0.79-1.36), nor a gene-gene interaction between NA1 and NAT2 (Pinteraction = 0.59), Further NAT1 alleles must be considered for more conclusive results regarding the relevance of NAT1 activity to colorectal tumorigenesis.
引用
收藏
页码:2125 / 2129
页数:5
相关论文
共 25 条
[21]  
Vatsis K. P., 1994, American Journal of Human Genetics, V55, pA340
[22]   NOMENCLATURE FOR N-ACETYLTRANSFERASES [J].
VATSIS, KP ;
WEBER, WW ;
BELL, DA ;
DUPRET, JM ;
EVANS, DAP ;
GRANT, DM ;
HEIN, DW ;
LIN, HJ ;
MEYER, UA ;
RELLING, MV ;
SIM, E ;
SUZUKI, T ;
YAMAZOE, Y .
PHARMACOGENETICS, 1995, 5 (01) :1-17
[23]   METABOLIC-ACTIVATION OF HETEROCYCLIC AROMATIC-AMINES CATALYZED BY HUMAN ARYLAMINE N-ACETYLTRANSFERASE ISOZYMES (NAT1 AND NAT2) EXPRESSED IN SALMONELLA-TYPHIMURIUM [J].
WILD, D ;
FESER, W ;
MICHEL, S ;
LORD, HL ;
JOSEPHY, PD .
CARCINOGENESIS, 1995, 16 (03) :643-648
[24]  
YANAGAWA Y, 1994, CANCER RES, V54, P3422
[25]   POLYMORPHIC DRUG-METABOLISM - STUDIES WITH RECOMBINANT CHINESE-HAMSTER CELLS AND ANALYSES IN HUMAN-POPULATIONS [J].
YOKOI, T ;
SAWADA, M ;
KAMATAKI, T .
PHARMACOGENETICS, 1995, 5 :S65-S69